Home » Topics » BioWorld Science

BioWorld Science
RSS

Enhanced chemotherapeutic efficacy reported for amsalog combination

Dec. 3, 1996

Aquaphore ointment protects premature infants from dermatological infections

Dec. 3, 1996

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

Osiris licenses inducing molecule involved in cartilage formation

Dec. 3, 1996

New tamoxifen combination effective against metastatic solid tumors

Dec. 3, 1996

Millipore to acquire business from W.R. Grace

Dec. 3, 1996

Avonex progresses toward European approval

Dec. 3, 1996

Merger creates new medical device company

Dec. 3, 1996

Apotex opens export-dedicated pharmaceutical facility

Dec. 3, 1996

Cathepsin B and L inhibitors described by Nippon Chemiphar

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...